Au

Mattel Once Again Says #ThankYouHeroes by Honouring Canadian Frontline Medical Worker with One-of-a-Kind Barbie Doll

Retrieved on: 
Wednesday, August 4, 2021

"I remember playing with Barbie as a young girl and imagining them as having the careers I aspired towards, even if the dolls weren't dressed like that career.

Key Points: 
  • "I remember playing with Barbie as a young girl and imagining them as having the careers I aspired towards, even if the dolls weren't dressed like that career.
  • To shine a light on their efforts, Barbie is sharing their stories to inspire the next generation to take after these heroes and give back.
  • "Barbie recognizes that all frontline workers have made tremendous sacrifices when confronting the pandemic and the challenges it heightened," said Lisa McKnight, Senior Vice President and Global Head of Barbie & Dolls, Mattel.
  • Today, Barbie is also introducing the Fast Cast Clinic playset, with a Barbie doctor doll and four distinct play areas: a medical station, an exam table, an x-ray machine and a gift shop.

Ms. Helen Hovenga Joins Telix as Chief People Officer

Retrieved on: 
Tuesday, August 3, 2021

MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive team in the role of Chief People Officer (CPO).

Key Points: 
  • MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive team in the role of Chief People Officer (CPO).
  • Helen joins from the Peter MacCallum Cancer Centre where she was Executive Director of People and Culture, overseeing 3,500 health practitioners and research employees.
  • On joining Telix, Ms. Hovenga stated, It is with great excitement that I join Telix.
  • Telix CEO, Dr. Christian Behrenbruch added, On behalf of the global team, I am delighted to welcome Helen to Telix.

Don’t miss Australia’s largest Aboriginal and Torres Strait Islander visual art event

Retrieved on: 
Tuesday, August 3, 2021

DARWIN, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Darwin Aboriginal Art Fair (DAAF) will open Friday 6 August via its cutting-edge digital platform, connecting audiences around the world with Australias Aboriginal and Torres Strait Islander creatives.

Key Points: 
  • DARWIN, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Darwin Aboriginal Art Fair (DAAF) will open Friday 6 August via its cutting-edge digital platform, connecting audiences around the world with Australias Aboriginal and Torres Strait Islander creatives.
  • Presented by Darwin Aboriginal Art Fair Foundation (DAAFF), now in its 15th year, the DAAF program will run from 6-11 August.
  • The program features a highly anticipated digital art fair and an online Public Program that includes artist masterclasses and artists talks.
  • For access to the Darwin Aboriginal Art Fair, register daaf.com.au/art-fair-2021

Activity Report for the Quarter ended June 2021

Retrieved on: 
Friday, July 30, 2021

SYDNEY, Australia, July 30, 2021 (GLOBE NEWSWIRE) -- Lithium Power International Limited (ASX: LPI) (LPI or the Company) is pleased to submit its quarterly Activity Report for the period ended 30 June 2021.

Key Points: 
  • SYDNEY, Australia, July 30, 2021 (GLOBE NEWSWIRE) -- Lithium Power International Limited (ASX: LPI) (LPI or the Company) is pleased to submit its quarterly Activity Report for the period ended 30 June 2021.
  • Drilling results showed positive average lithium concentrations of 989 mg/l, with a maximum of 3,375 mg/l, confirms Maricunga as one of the richest deposits globally.
  • An initial 1600m RC Drilling program to commence at the East Kirup lithium anomaly in December 2021.
  • To read the companys full Report and results in detail for Q2 2021, please click here

Appendix 4C Quarterly Activity Report

Retrieved on: 
Friday, July 30, 2021

Total Operating Activities resulted in net cash usage of US$20.7 million in the quarter ended June 30, 2021.

Key Points: 
  • Total Operating Activities resulted in net cash usage of US$20.7 million in the quarter ended June 30, 2021.
  • This included an investment of US$10.8 million associated with remestemcel-L for SR-aGVHD and COVID-19 ARDS.
  • Specifically:
    Revenues from TEMCELL royalties for the quarter ended June 30, 2021 were US$1.9 million compared to US$0.7 million in the quarter ended June 30, 2020.
  • The DSMB recommended that the trial complete with the enrolled 222 patients, and that all be followed-up as planned.

US Patent Office issues Notice of Allowance status for NRGBiotic™ for treating, preventing, or Ameliorating depression or a Depressive disorder.

Retrieved on: 
Tuesday, July 27, 2021

The patent covers both the formulation of NRGBiotic and a method for treating, preventing, or ameliorating at least one symptom of depression or a depressive disorder and is valid through to 28 October 2035.

Key Points: 
  • The patent covers both the formulation of NRGBiotic and a method for treating, preventing, or ameliorating at least one symptom of depression or a depressive disorder and is valid through to 28 October 2035.
  • Dr Sean Hall, CEO of Medlab stated the USPTO decision to allow is welcoming news.
  • NRGBiotic has both the formulation and capabilities of that formulation previously approved in Australia.
  • From a commercial aspect, NRGBiotic is a branded line here in Australia, and will now go to our partnering network in the Northern Hemisphere.

Mladen Kljaic's MKM Group completes Stage 7A Orchard Grove

Retrieved on: 
Tuesday, July 27, 2021

SYDNEY, NSW, July 27, 2021 (GLOBE NEWSWIRE) -- Mladen Kljaic has been forging ahead with MKM Group Australia completing the civil works and land development for Stage 7A.

Key Points: 
  • SYDNEY, NSW, July 27, 2021 (GLOBE NEWSWIRE) -- Mladen Kljaic has been forging ahead with MKM Group Australia completing the civil works and land development for Stage 7A.
  • This has allowed builders to set up and start construction of residential homes and duplexes in this latest stage in Orchard Grove, Warwick.
  • Given that these properties sold so quick and construction is well under way, MKM Group Mladen Kljaic are preparing for another stage with 31 lots to be released soon.
  • The development at Warwick by MKM Group Australia Pty Ltd is having all the sales handled by the professional team at Aus Sales Real Estate.

Genetic Technologies Rapidly Accelerating Commercialization Plans

Retrieved on: 
Monday, July 26, 2021

The Company has previously outlined its key avenues for commercialization which currently include the consumer-initiated online sales and marketing platform (CIT) available in Australia and the US.

Key Points: 
  • The Company has previously outlined its key avenues for commercialization which currently include the consumer-initiated online sales and marketing platform (CIT) available in Australia and the US.
  • Additionally, GTG is engaging in business to business (B2B) sales via medical professionals and now has distribution coverage of the Australian and US markets.
  • The Multitest will leverage the foundational IP granted under US Patent 7,127,355 Methods for Genetic Analysis.
  • The increased sample numbers have enabled separation into test and validation datasets, a key requirement for commercialization.

Wyloo Metals confirms its intention to convert loan

Retrieved on: 
Saturday, July 24, 2021

PERTH, Australia, July 23, 2021 (GLOBE NEWSWIRE) -- Wyloo Metals Pty Ltd. (Wyloo Metals) is pleased to provide an update in relation to the US$15 million convertible loan (the Convertible Loan) provided to Noront Resources Ltd. (TSXV:NOT) (Noront).

Key Points: 
  • PERTH, Australia, July 23, 2021 (GLOBE NEWSWIRE) -- Wyloo Metals Pty Ltd. (Wyloo Metals) is pleased to provide an update in relation to the US$15 million convertible loan (the Convertible Loan) provided to Noront Resources Ltd. (TSXV:NOT) (Noront).
  • On December 7, 2020, Wyloo Canada Holdings Pty Ltd (Wyloo Canada), a wholly-owned subsidiary of Wyloo Metals, entered into an agreement with Resource Capital Fund V L.P. (RCF) to acquire its interests in Noront, including the Convertible Loan.
  • The maturity date of the loan is September 30, 2021 and it is convertible into common shares of Noront at the option of Wyloo Metals at Cdn$0.20 per common share.
  • Wyloo Metals confirms that it intends to convert the Convertible Loan at or before the maturity date into common shares of Noront, rather than seek repayment from Noront in cash.

Gelteq Appoints Seasoned Pharma and Tech Executive, James Pekarsky, as Chief Financial Officer

Retrieved on: 
Thursday, July 22, 2021

Pekarsky brings to Gelteq more than 30 years of finance and executive experience at biotech and technology companies.

Key Points: 
  • Pekarsky brings to Gelteq more than 30 years of finance and executive experience at biotech and technology companies.
  • We welcome Jims extensive financial knowledge and operational experience, particularly his success with developing novel pharma delivery systems, stated Simon Szewach, Gelteq co-founder and executive chairman.
  • His proven capabilities and knowhow greatly complement our fast-track for growth and our expanding team of industry pioneers.
  • The sports, health and wellness, and pharma partnerships the company has formed are impressive and support its commercial rollout.